PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
DelveInsight

Press Release


Receive press releases from DelveInsight: By Email RSS Feeds:

Coming Soon: DelveInsight Brand New Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015 Report


DelveInsight has launched its Antibody-Drug Conjugate Report giving Pipeline and global Market Outlook.

Delhi, India, April 09, 2015 --(PR.com)-- DelveInsight, the leading Business consultant and Market Research Firm is proud to announce the pre-launch of it Report, Antibody-Drug Conjugate-Global Market and Pipeline Outlook, 2015. The Report has highlighted the Antibody drug conjugate technologies, novel ADC platforms, novel payloads, linkers, company’s collaborations and descriptive ADCs Pipeline profiles.

Antibody-Drug Conjugates report has uncovered the potential of global ADC Market with insights into 6 Therapy Areas with collective pipeline of more than 264 ADCs and the companies at their forefront. The report has also provided the core information of the targets, mechanism of action, development partner, technology partner, monoclonal antibody used, linker used and cytotoxic drug with the descriptive information of the technologies. The report has also assessed the ADCs on geographical distribution based on the country and region.

DelveInsight is also giving a limited period Pre-Launch offer of USD 500 off on this Report. The Report is available at USD 3500 as a single user license, USD 7000 as a site license and USD 10500 as a Global/Enterprise License.

Book now for maximum appreciation of your investment!

For more information, email at info@delveInsight.com
Contact Information
DelveInsight
Mridhu Verma
+91-11-4568 9769
Contact
www.delveinsight.com

Click here to view the list of recent Press Releases from DelveInsight
Promote Your Business